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Abstract
Tec family non-receptor tyrosine kinases (Itk, Btk, Tec, Rlk and Bmx) are characterized by the presence of an
autophosphorylation site within the non-catalytic Src homology 3 (SH3) domain. The full length Itk mutant
containing a phenylalanine in place of the autophosphorylated tyrosine has been previously studied in Itk
deficient primary T cells. These studies revealed that the nonphosphorylated enzyme only partially restores
Itk mediated signaling. In spite of these insights, the precise role of the Tec kinase autophosphorylation site
remains unclear and the mechanism of the autophosphorylation reaction within the Tec kinases is not known.
Here we show both in vitro and in vivo that Itk autophosphorylation on Y180 within the SH3 domain occurs
exclusively via an intramolecular, in cis mechanism. Using an in vitro kinase assay we also show that mutation
of the Itk autophosphorylation site Y180 to Phe decreases kinase activity of the full-length enzyme by
increasing Km for a peptide substrate. Moreover, mutation of Y180 to Glu, a residue chosen to mimic the
phosphorylated tyrosine, alters the ligand binding capability of the Itk SH3 domain in a ligand dependent
fashion. NMR chemical shift mapping gives residue-specific structural insight into the effect of the Y180E
mutation on ligand binding. These data provide a molecular level context with which to interpret in vivo
functional data and allow development of a structural model for Itk autophosphorylation.
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Abstract
Tec family non-receptor tyrosine kinases (Itk, Btk, Tec, Rlk and Bmx) are characterized by the
presence of an autophosphorylation site within the non-catalytic Src homology 3 (SH3) domain. The
full length Itk mutant containing a phenylalanine in place of the autophosphorylated tyrosine has
been previously studied in Itk deficient primary T cells. These studies revealed that the non-
phosphorylated enzyme only partially restores Itk mediated signaling. In spite of these insights, the
precise role of the Tec kinase autophosphorylation site remains unclear and the mechanism of the
autophosphorylation reaction within the Tec kinases is not known. Here we show both in vitro and
in vivo that Itk autophosphorylation on Y180 within the SH3 domain occurs exclusively via an
intramolecular, in cis mechanism. Using an in vitro kinase assay we also show that mutation of the
Itk autophosphorylation site Y180 to Phe decreases kinase activity of the full-length enzyme by
increasing Km for a peptide substrate. Moreover, mutation of Y180 to Glu, a residue chosen to mimic
the phosphorylated tyrosine, alters the ligand binding capability of the Itk SH3 domain in a ligand
dependent fashion. NMR chemical shift mapping gives residue-specific structural insight into the
effect of the Y180E mutation on ligand binding. These data provide a molecular level context with
which to interpret in vivo functional data and allow development of a structural model for Itk
autophosphorylation.
Keywords
Tec kinases; autophosphorylation; SH3 domain; SH2 domain; proline rich ligand; Itk
INTRODUCTION
Phosphorylation cascades mediated by protein tyrosine kinases are initiated in a rapid fashion
following ligand engagement of extracellular receptors such as the T cell receptor. Several
distinct families of protein kinases play critical roles in the signaling processes that control T
cell activation. Specifically, engagement of the T cell receptor leads to the activation of the
lipid kinase phosphoinositide 3-kinase (PI3K) and the Syk family kinase, Zap-70. Activation
of PI3K leads to the formation of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3),
a ligand for the PH domain of Itk. Zap-70 phosphorylates the adaptor protein, LAT (Linker for
activation of T cells) creating a binding site for the Tec family kinase Itk within the LAT/SLP76
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(SH2-domain-containing leukocyte protein of 76 kDa) signaling complex1; 2. Binding of
PtdIns(3,4,5)P3 by the PH domain of Itk and phospho-SLP76/LAT complex by the SH2 domain
of Itk recruites Itk to the membrane signaling complex. The Src family kinase, Lck,
phosphorylates Itk on Y511, a residue that resides in the activation loop of the Itk kinase domain
and which must be phosphorylated for subsequent Itk catalytic activity3. Itk also
autophosphorylates Y180 in its own SH3 domain4. Activated Itk phosphorylates phospholipase
C-γ15; the enzyme responsible for hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdIns
(4,5)P2) to diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3). From here, DAG and
IP3 mediate intracellular calcium flux and activation of the Ras-Raf-MEK-ERK pathway that
lead to cytokine production and T cell proliferation6; 7.
Our interests have rested on understanding the molecular details of the complex regulation of
Tec family kinase signaling. The Tec family of non-receptor tyrosine kinases consists of five
members: Tec, Btk, Rlk/Txk, Bmx/Etk and Itk. All Tec kinases contain a Src homology 3
(SH3), Src homology 2 (SH2) and kinase domain, and (with the exception of Rlk) also contain
an N-terminal pleckstrin homology (PH) and Tec homology (TH) domain. We and others have
reported that the non-catalytic regulatory domains of the Tec kinases mediate self-association
of these enzymes both in vitro and in cells8; 9; 10; 11; 12; 13. Intermolecular self-association
might suggest that the Tec kinase autophosphorylation step occurs in trans yet to date the
precise mechanism of autophosphorylation has not been elucidated. In addition to mechanistic
considerations, the functional significance of Tec kinase autophosphorylation is not yet firmly
established. While mutation of the Lck phosphorylation site, Y511, to phenylalanine in Itk
renders Itk catalytically impaired and results in severely defective cytokine production and
ERK activation in activated T cells3, disruption of the autophosphorylation site in the Itk SH3
domain (by mutation of Y180 to Phe) only partially alters downstream signaling4. Related
studies in B cells found that the Btk Y223F mutant (corresponding to Itk Y180) was able to
partially restore calcium mobilization and PLC-γ2 phosphorylation in a Btk deficient cell
line14; 15, whereas in another study the same Y223F mutation enhanced the oncogenic ability
of a gain-of-function Btk mutant16.
The effect of mutation at the autophosphorylation site in the SH3 domain has been difficult to
interpret as the experimental outcome seems to be dependent on the assay system used14; 15;
16. In an effort to better understand the observed effects of the Y180F/Y223F mutations in
cells, in vitro kinase assays have been carried out using immunoprecipitated Tec kinases4;
16. The results of these experiments suggest that the Itk Y180F and Btk Y223F mutant enzymes
exhibit similar catalytic activity to the wild type enzyme. Complementing these functional data,
binding studies of the phosphorylated Btk SH3 domain suggest that modification of Y223 alters
ligand affinity17. Thus, altered ligand binding of the Itk(Y180F) mutant rather than changes in
catalytic activity is currently presumed to be the explanation for the differences in the activity
of the full-length wild type and Y180F Itk proteins in T cells4.
Given the complexity of the in vivo experiments and the qualitative nature of the in vitro kinase
assays carried out to date, we decided to address the significance of Itk autophosphorylation
using quantitative biochemical and structural approaches. In this report we show that the SH3
domain of the Itk Y180F mutant is partially ‘trapped’ in a conformation where it occupies the
active site of the Itk kinase domain. Consistent with a steric block of the active site, the Itk
Y180F mutant is characterized by a moderately higher Km but the same kcat for a peptide
substrate compared to the wild-type enzyme. In addition to modulating this kinetic parameter
of full length Itk, SH3 mediated ligand binding is also affected by mutation of Y180. Replacing
Y180 within the isolated SH3 domain to Glu to mimic a phosphorylated Tyr has opposite
effects on the affinity of different ligands. NMR chemical shift mapping experiments show
that the SH3 Y180E mutation causes structural perturbations that extend into the ligand-binding
pocket. We also show that the Itk autophosphorylation reaction occurs by an intramolecular,
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in cis mechanism both in vitro and in vivo. Thus, the autophosphorylated Tyr in the SH3 domain
is only phosphorylated by the kinase domain in the same molecule and not by a separate Itk
molecule. Together, these data provide molecular level insights into previous experiments that
probed the role of Itk autophosphorylation in T cell activation. Our data point to changes in
both ligand binding by the SH3 domain and kinetic parameters of the enzyme itself that likely
contribute to the partial activity of the Itk Y180F mutant that has been previously studied in
the context of T cells deficient in wild type Itk.
RESULTS
Mechanism of Itk autophosphorylation
To test whether Itk autophosphorylation occurs via an intramolecular, in cis or an
intermolecular, in trans mechanism, we constructed several Itk deletion variants (Fig. 1A) and
measured the phosphorylation of Y180 in a series of mixing experiments. Mixing full length
Itk and shorter Itk deletion fragments allows for separate visualization of kinase active (WT)
and kinase inactive (K390R) enzymes by western blot.
We tested the extent to which a kinase inactive mutant of Itk (K390R) is phosphorylated on
Y180 in trans by incubating it with catalytically active Itk. First, purified FLAG-tagged, active
full-length WT Itk is incubated with three different N-terminal deletion fragments of inactive
(K390R) Itk in a 1:1 ratio and subjected to in vitro kinase assay conditions (Fig. 1B). The
proteins were separated by SDS-PAGE and then probed by western blotting with a Btk pY223
specific antibody (previously used to detect specific phosphorylation on Itk Y180)4. As shown
in lanes 1–4 of Figure 1B, only full-length, kinase active Itk is phosphorylated on Y180, while
none of the kinase inactive Itk fragments are phosphorylated on this residue. Reversal of the
scheme by incubation of the kinase active 32KD fragment of Itk with either kinase inactive
(K390R) full-length Itk or the kinase inactive deletion fragments of Itk shows that only the
kinase active 32KD fragment is phosphorylated on Y180 and that neither the inactive full-
length Itk nor the inactive Itk fragments are phosphorylated on Y180 (Fig. 1B, lanes 5–8).
These data indicate that autophosphorylation of Itk occurs exclusively in an intramolecular,
in cis fashion. The absence of in trans autophosphorylation is not due to the inability of the
fragments of Itk to associate intermolecularly with full length Itk as shown by the pull-down
assay in Figure 1C. Purified FLAG-tagged Itk 32KD immobilized on an anti-FLAG resin
readily interacts with full-length untagged Itk expressed in Sf9 cells. We have also previously
demonstrated that deletion of the PH domain of Itk does not significantly affect the catalytic
activity (kcat/Km) of Itk18. These data indicate that in spite of self-association of Itk, in vitro
autophosphorylation of Itk on Y180 occurs in cis.
To explore the mechanism of Itk autophosphorylation in vivo, we tested the extent to which
kinase inactive Itk 32KD (K390R) fragment can be phosphorylated in trans by full-length wild-
type Itk, by co-expressing FLAG-tagged versions of both in Sf9 cells. The extent of
phosphorylation on Y180 was assessed by immunoprecipitating the proteins using an anti-
FLAG resin, and western blotting with a pY180 specific antibody as before. As shown in Figure
1D, while kinase active Itk, either full length or 32KD, are efficiently phosphorylated on Y180,
the kinase inactive Itk 32KD (K390R) fragment is not phosphorylated on Y180 even when co-
expressed with wild type Itk. These results perfectly mirror the in vitro results already
described, providing further indication that autophosphorylation of Itk on Y180 within the SH3
domain is an intramolecular reaction.
Absence of Y180 phosphorylation influences Km
Previous analysis of the full-length Itk Y180F mutant in vivo showed that this mutant has partial
activity4. As well, previous in vitro analyses using immunoprecipitated enzymes suggested
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that the activity of the Y180F mutant does not differ from WT4. In order to quantitatively
compare the in vitro kinase activity of the full length wild type Itk and the Itk Y180F mutant
lacking the autophosphorylation site, we determined the kinetic parameters of wild type Itk
and Itk Y180F mutant using Sf9 purified enzymes (Fig. 2A & B). The Km and kcat values for
ATP are unaffected by the Y180F mutation (Fig. 2A and B). The kcat values for wild-type Itk
and the corresponding Itk Y180F mutant are also identical within experimental error. In
contrast, the Km value for the peptide substrate differs between wild-type Itk and the Itk Y180F
mutant resulting in nearly a factor of three difference in kcat/Km (Fig. 2A and B).
Western blot analysis of the proteins using phosphospecific antibodies confirmed that wild-
type Itk and the Y180F mutant are equally phosphorylated on Y511 and that, as expected, wild
type Itk alone is phosphorylated on Y180 (Fig. 2C). Full length kinase inactive (K390R) Itk
showed negligible activity when compared to wild-type enzyme confirming that the activity
being measured in Figure 2A corresponds to that of Itk and not to co-purifying impurities (Fig.
2D). Thus, differences in activation loop (Y511) phosphorylation levels and/or possible
impurities in the Itk preparations do not account for the observed differences in Km values
between wild-type and Y180F Itk.
Another possible explanation for the observed increase in Km upon mutation of Y180 to
phenylalanine stems from our recently reported results regarding substrate recognition by Itk
and related Tec kinases19. In that work we demonstrated that the Itk kinase domain recognizes
the autophosphorylation site in the SH3 domain via direct binding to the adjacent Itk SH2
domain. The Itk kinase domain binds directly to the SH2 domains of its substrates mediating
specific phosphorylation of the target tyrosine residue. Since full length Y180F Itk contains
no mutations in either the SH2 or kinase domains, the SH2-mediated docking mechanism
should be maintained in the Itk Y180F mutant and, as a result, the SH3 domain harboring the
Y180F mutation is likely positioned within the active site of Itk regardless of its inability to
be phosphorylated. Indeed, the fact that the phenylalanine side chain cannot be phosphorylated
suggests that the Y180F mutant may form a dead-end intramolecular complex leading to an
apparent increase in Km for the peptide substrate (Fig. 2A and B).
To test this hypothesis we followed up on our earlier observation that addition of isolated Itk
SH2 domain to the in vitro kinase reaction will directly compete with docked substrate and
reduce Y180 autophosphorylation19. This suggests that addition of excess SH2 domain to the
kinase assay should disfavor formation of the dead-end complex and eliminate competition
between the Y180F SH3 domain and the peptide substrate for the active site. The kinetic
parameters of the Itk Y180F mutant were therefore measured with the addition of isolated SH2
domain to the assay conditions (Fig. 2A). The saturation curves for full-length wild type Itk
alone and the Itk Y180F mutant in the presence of free SH2 domain are identical. Exogenous
free Itk SH2 domain restores the Km for Peptide B of the Itk Y180F mutant to that of wild-type
Itk (Fig. 2A and B). Thus, the decrease in kcat/Km for the Itk Y180F mutant likely reflects
reduced peptide substrate binding to the Itk active site due to steric occlusion by the mutant
SH3 domain. These measurements therefore suggest that, at least in part, the diminished
activity observed for the Itk Y180F mutant in vivo4 likely arises from formation of a dead-end
intramolecular complex that reduces substrate phosphorylation by increasing Km for
exogenous substrates. With regard to reported similarities between in vitro activities of
wildtype and Y180F mutant Itk using immunoprecipitated enzymes4, we expect that the
differences in Km of the magnitude that we measure here would not be readily detected by
qualitative western blot approaches used previously.
Modulation of ligand affinity by an SH3 Y180E mutation
SH3 domains are well known ligand binding modules and so we also investigated the extent
to which autophosphorylation of the Itk SH3 domain might influence ligand binding affinity.
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Structures of the SH3 domains of three of the Tec kinases have been solved and clearly
demonstrate that the autophosphorylated tyrosine is located within the conserved SH3 binding
pocket11; 20; 21. The Itk SH3 domain has been shown to bind two disparate ligands, the
canonical proline-rich peptide and the SH2 domain of Itk8; 22. Both ligand-binding events
involve the conserved aromatic cleft of the SH3 domain that contains Tyr 180.
NMR spectroscopy provides a means to evaluate the molecular details of how
autophosphorylation at position 180 in the SH3 domain influences ligand binding. As already
described however, the SH3 domain alone is not a good substrate for the Itk kinase (presence
of the SH2 domain within the substrate is required to achieve efficient phosphorylation of
Y18019) and so production of sufficient quantities of phosphorylated SH3 domain in isolation
for NMR analysis is impractical. We therefore opted to mutate Y180 in the isolated SH3 domain
to the negatively charged amino acid glutamate, a reasonable mimic for a phosphorylated side
chain23; 24; 25; 26. NMR chemical shift perturbations reveal that mutation of the Itk SH3 Tyr
180 to Glu brought about a 13-fold reduction in the affinity of the SH3 domain for a canonical
proline rich peptide (Fig. 3A, B, E). Conversely, the Itk SH3 Y180E mutation leads to a 6 times
increase in the affinity for the Itk SH2 domain (Fig. 3C, D, E). Thus, replacing Y180 within
the Itk SH3 domain with a negatively charged side chain alters ligand binding affinity and the
magnitude and nature of the effect appears to be ligand specific.
To more carefully dissect the differences in ligand binding affinity observed upon introducing
a negative charge into the SH3 binding surface, we mapped the chemical shift perturbations
that are induced upon canonical peptide ligand binding or Itk SH2 domain binding to either
wild type Itk SH3 or the Y180E SH3 mutant (Fig. 4A–E). Chemical shift changes that occur
upon ligand binding indicate SH3 surface residues that either directly contact the ligand or are
indirectly affected by ligand binding (such as by conformational changes in the SH3 domain
that are a result of ligand binding). Multiple structures of proline-rich peptides bound to SH3
domains are available27 and all show a conserved recognition motif consisting of two adjacent
binding clefts (labeled I and II in Fig. 5) on the SH3 surface that contact the aliphatic-proline
dipeptide segments of the proline-rich ligand (Fig. 5A). The binding surface that is mapped
upon titration of the GWYSKPPPPIP peptide into the wild type Itk SH3 domain (Fig. 5B) is
consistent with the structure of a related peptide bound to this SH3 domain (Fig. 5A).
Titration of the same peptide into the Y180E SH3 domain reveals a different pattern of chemical
shift perturbations (Fig. 5C). Notably, for the Itk Y180E mutant, resonances corresponding to
the key regions in the wild type SH3 domain that contact the bound peptide (conserved binding
clefts I and II) either do not exhibit chemical shift changes upon peptide binding (cleft I) or
only partially exhibit chemical shift perturbations (cleft II). These data suggest that the
canonical peptide ligand associates with the Y180E mutant in a manner that is distinct from
association with wild type SH3 and provide insight into the observed decrease in affinity that
accompanies mutation of Y180 to glutamate.
The basis for the differences in peptide binding to wild type and Y180E SH3 domain becomes
more apparent upon comparison of resonance frequencies for the wild type and Y180E SH3
domains in the absence of peptide ligand (Figs. 4C, 5F). In Figure 5F the SH3 residues for
which significant chemical shift differences are apparent between wild type and Y180E SH3
domains are highlighted on the surface of the domain. The changes are not localized to the
region immediately surrounding the site of mutation (position 180) but rather are directed into
the peptide binding pocket and coincide remarkably well with the residues that do not exhibit
chemical shift perturbations in the Y180E mutant upon peptide binding (Fig. 5C). The data
suggest that insertion of a negative charge at position 180 modulates the SH3 binding surface
in a manner that disrupts the primary sites of ligand contact (clefts I and II, Fig. 5F) causing
the peptide ligand to alter its interaction with the SH3 surface. Consequently, canonical binding
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of the GWYSKPPPPIP peptide is disfavored and the affinity drops significantly (Fig. 3A, B
and E). These data provide insight into how autophosphorylation at Y180 might alter ligand
binding to the Itk SH3 domain during signaling. Indeed, given the size and charge differences
between a phosphate and the carboxylic acid of glutamate, the effects on ligand binding affinity
may be more pronounced for the phosphorylated SH3 domain than those observed for Y180E
mimic.
In contrast to the decrease in affinity observed for the proline rich peptide ligand used in this
study, the Itk SH3 Y180E mutation leads to an increase in affinity for the Itk SH2 domain (Fig.
3C, D and E). Surface mapping of the chemical shift changes induced upon binding of the Itk
SH2 domain by either wild-type Itk SH3 domain or SH3 Y180E shows significant similarity
(Fig. 5D and E). Consistent with the observed increase in affinity of the Itk SH2/SH3(Y180E)
interaction, the surface defined by chemical shift perturbations for the Itk SH2/SH3(Y180E)
interaction is more extensive than that of the wild-type Itk SH2/SH3 interaction. The Y180E
mutation likely provides an additional contact to a residue or residues of the SH2 ligand leading
to the observed affinity increase. At this juncture, we also measured the affinity of the Itk SH2
domain binding to the SH3(Y180F) mutant. In this case we find that the tyrosine to
phenylalanine mutation alters the interaction with the SH2 domain to only a small extent (Kd
= 0.4 ± 0.2 mM) providing further support that the tyrosine to glutamate mutation (or
phosphorylation of Y180) likely causes a significant change in SH3 mediated ligand binding.
A precise description of the molecular determinants of the observed affinity increase must
await full structure determination of this non-canonical SH3 interaction. Together, the two
examples of ligand binding by the Itk SH3 domain examined here demonstrate that
autophosphorylation in the SH3 binding pocket can have distinct consequences in ligand
recognition and binding affinity.
DISCUSSION
Each of the Tec family kinases is characterized by the presence of an autophosphorylation site
within their SH3 domain28 yet the functional significance and mechanism of this
autophosphorylation event in Tec kinase mediated signaling have remained unclear. The data
presented here clearly demonstrate an in cis autophosphorylation mechanism for Itk in spite
of earlier observations that Itk and the other Tec kinases self-associate in an intermolecular
fashion. Given the similarities in the domain structures of the Tec kinases, it is reasonable to
expect that like Itk, the other Tec family kinases undergo autophosphorylation in cis.
In an effort to obtain a structural model of the in cis autophosphorylation of the Itk SH3 domain
we made use of the fact that structures have been solved for each of the individual domains of
interest20; 29; 30. The structure of the isolated Itk kinase domain (PDB ID 1SNX) was aligned
with the structure of the insulin receptor kinase domain that is bound to a tyrosine containing
peptide substrate31 (PDB ID 1IR3). Tyr180 within the Itk SH3 domain was then superimposed
with the tyrosine of the bound peptide substrate of the insulin receptor kinase (Fig. 6A). Simple
alignment of these two target tyrosine residues (Y180 in the Itk SH3 domain and the peptide
substrate tyrosine in the insulin receptor kinase structure) with no further adjustment results in
a remarkable fit of the Itk SH3 domain within the Itk kinase domain active site (Fig. 6B and
C). The intervening SH2 domain can also be included in the model. The amino terminus of the
SH2 domain must be positioned such that it is covalently linked to the carboxy terminus of the
SH3 domain. The carboxy terminus of the SH2 domain leads to the 17 amino acid linker
between the SH2 and kinase domains. Biochemical evidence suggests that the 17 amino acid
linker contacts the small lobe of the kinase domain in a manner that resembles the structure of
Csk18; 32. Given these structural restraints and the fact that the Itk SH2 domain binds directly
to the Itk kinase domain in a substrate docking role we can place the SH2 domain into this
model for Itk autophosphorylation (Fig. 6A). The model is also consistent with SAXS analysis
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of full-length Btk33, where the SH2 domain is predicted to be located close to the N-terminal
lobe of the kinase domain (Fig. 6A). Thus, the in cis autophosphorylation mechanism predicts
that, during the course of the autophosphorylation reaction, the position of the SH3 and SH2
regulatory domains of Itk with respect to the catalytic kinase domain is distinct from related
enzymes such as Src34, Abl35 and Csk32. Furthermore, this regulatory region must be flexible
enough to position the SH3 domain within the kinase active site in an intramolecular manner.
Previous in vivo work analyzing the effect of mutation at the site of autophosphorylation
suggested that the unphosphorylated Itk Y180F mutant exhibits partial activity4. The
quantitative in vitro kinase assays reported here show that the kcat values for both the purified
wild-type enzyme and Itk Y180F full-length mutant are indistinguishable (Fig. 2A and B).
However, the Itk Y180F mutant is characterized by a modestly higher Km for peptide B when
compared to the wild-type enzyme. This apparent increased Km for peptide B phosphorylation
by the Itk Y180F mutant is restored to that of wild type enzyme in the presence of excess free
Itk SH2 domain. This result suggests that the Itk Y180F mutant enzyme forms a dead end
complex that is disrupted by excess SH2 domain that competes for the docking site on the Itk
kinase domain. Thus, the decreased activity of the Itk Y180F mutant reported in vivo is likely
due in part to decreased substrate binding affinity; physiological substrates must compete with
this dead end complex for binding to the active site of Itk. We conclude that Tec kinase
autophosphorylation per se plays no role in regulating the catalytic activity of Itk since loss of
the autophosphorylation site in the Itk SH3 domain has no measurable effect on the catalytic
activity (either Km or kcat) of full length Itk provided these measurements are made under
conditions that disfavor formation of the dead end complex. Since the primary function of the
SH3 domain is ligand binding, the predominant role of Tec family autophosphorylation is
therefore likely related to this function. This has been put forth previously4; 16; 17 and we now
provide molecular level insight into how phosphorylation triggers changes in ligand
recognition.
Structures of the SH3 domains of Btk, Tec and Itk all show that the autophosphorylated Tyr
is located within the conserved ligand-binding pocket11; 20; 21. In a previously reported study,
pull-down experiments using phosphorylated Btk SH3 domain indicated that only a subset of
the SH3 mediated interactions are disrupted by tyrosine phosphorylation in the SH3 binding
pocket17. In that work, the unphosphorylated SH3 domain of Btk interacts with proline-rich
regions of c-Cbl and Wiskott-Aldrich syndrome protein (WASP), and the phosphorylated Btk
SH3 domain interacts with c-Cbl but not WASP. Here NMR data suggest that the ligand binding
affinity of the Itk SH3 domain can also be modulated by autophosphorylation in a ligand
dependent manner and that the decrease in binding affinity of the canonical proline-rich ligand
for the SH3 domain can be directly attributed to structural perturbations in the SH3 ligand
binding clefts. Specifically, chemical shift perturbation analysis indicates that addition of a
negatively charged residue at position 180 in the Itk SH3 domain leads to very directed changes
on the SH3 surface (Fig. 5F) that are localized to the conserved binding clefts I and II. The
apparent reduction of affinity for the proline-rich peptide ligand for this region, as evidenced
by lack of chemical shift perturbations in the corresponding region upon titration of peptide
into the Y180E mutant, suggests that autophosphorylation re-tunes the SH3 surface in a very
precise and specific manner.
Quantitative kinetic analysis combined with NMR spectroscopic approaches now allow us to
provide a refined interpretation of the factors leading to defects in Itk function observed by
disrupting Itk autophosphorylation in T cells4. First, a decrease in substrate affinity (increased
Km) due to formation of a dead-end complex mediated by SH2 domain docking is observed
for full length Itk Y180F. This suggests that this same Y180F mutant in primary T cells likely
exhibits decreased kinase activity. Second, quantitative ligand binding affinity measurements
for the Y180E SH3 domain show that binding of one ligand is increased and another decreased
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upon introduction of a negatively charged residue in the SH3 binding pocket. Thus, the inability
of the full length Y180F mutant in Itk-deficient primary T cells to fully restore signaling arises
from the balance of changes in kinase function and ligand dependent changes in the ligand
binding affinity of the Itk SH3 domain.
MATERIALS AND METHODS
Materials
The proline rich peptide (GWYSKPPPPIP) with high affinity for Itk SH3 domain36 was
obtained from Genscript. The anti-pY223 Btk antibody (corresponding to Itk pY180), and anti-
pY551 Btk antibody (corresponding to Itk pY511) were obtained from Dr. Owen Witte.
Constructs
Full-length and N-terminal deletion mutants of wild-type (WT) and kinase dead (K390R) Itk
(mouse sequence) were PCR amplified using a reverse primer which encoded a FLAG epitope
tag. The PCR products were cloned into the pENTR/D-TOPO vector (Invitrogen) by TOPO
cloning. Point mutations in the full-length Itk construct were created by using the site-directed
mutagenesis (SDM) kit (Stratagene). Bacterial expression constructs for Itk SH2 domain and
SH3 domain have been described earlier8. The Y180E and Y180F point mutations in the Itk
SH3 domain were introduced by SDM as before. All constructs were verified by sequencing
at the Iowa State University DNA synthesis and sequencing facility.
Baculovirus production
The pENTR vectors with various inserts were recombined in vitro with BaculoDirect C-Term
Linear DNA (Invitrogen) using LR Clonase II enzyme according to the manufacturers
instructions (Invitrogen). The DNA was then transfected into Sf9 cells using Effectene (Qiagen)
according to the manufacturers instructions. Three rounds of viral selection and amplifications
were carried out as described in the instruction manual (Invitrogen). For protein production,
the cells were infected with a 1:1 ratio of Itk: Lck baculovirus to ensure uniform
phosphorylation of Y511 in Itk. The cells were harvested 72 hrs post-infection, rinsed once
with phosphate buffered saline (PBS) and stored at −80°C.
Protein purification
Bacterially expressed proteins were purified as described earlier8. Sf9 protein purification was
carried as previously described with minor modifications37. Briefly, the cell pellets were
resuspended in lysis buffer (50 mM Tris pH 8.0, 500 mM NaCl, 2 mM EDTA, 1 mM PMSF)
and lysed by dounce homogenization. The homogenate was spun at 16K for 1hr at 4°C.
Glycerol was added to the supernatant to a final volume of 10%, and then incubated with anti-
FLAG M2 affinity resin (Sigma) for 5hrs at 4°C. The resin was rinsed five times in wash buffer
(50 mM Tris pH 8.0, 500 mM NaCl, 1 mM PMSF, 10% glycerol), and the protein was eluted
in elution buffer (wash buffer with 200 μg/ml FLAG peptide) and stored at −80°C. The purified
protein was quantified by measuring absorbance at 280 nM. All proteins were greater than 95%
pure by Coomassie staining.
Kinase assay
Kinase assays were carried out as described previously18. Km determinations for Peptide B
[(Aminohexanoyl biotin-EQEDEPEGIYGVLF-NH2) (Anaspec Inc.)] or ATP were carried out
by incubating purified enzyme in reaction buffer (50 mM Hepes pH 7.0, 10 mM MgCl2, 1 mM
DTT, 1 mg/ml BSA, and 1 mM Pefabloc) and 5 μCi [32P] ATP (Amersham Biosciences) at
room temperature. Peptide B concentration was varied between 0 and 400 μM. ATP
concentration was varied between 0 and 320 μM. The enzyme concentration used was 250nM.
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Each assay was done in duplicate. The data obtained was fit onto the Michealis-Menten
equation using GraphFit 5 software, and the kinetic parameters were obtained.
In vitro kinase assay and western blotting
Full-length Itk WT or Itk 32Kinase domain WT fragment was incubated in a 1:1 ratio with
various kinase inactive (K390R) deletion fragments in kinase assay buffer (50 mM Hepes pH
7.0, 10 mM MgCl2, 1 mM DTT, 1 mg/ml BSA, 1 mM Pefabloc and 200 μM ATP) for one
hour at RT. The samples were boiled, separated by SDS-PAGE and transferred onto a PVDF
membrane. The membranes were then blotted with either an anti-pY223 Btk antibody, or anti-
pY551 Btk antibody or anti-FLAG antibody (Sigma) and developed using a chemiluminescent
substrate (Pierce).
NMR Titrations
NMR Spectra were acquired using a Bruker DRX500 spectrometer operating at 1H frequency
of 499.867 MHz. All spectra were obtained at 298K. 1H and 15N chemical shifts were externally
referenced to DSS in identical buffer. NMR titrations were carried out as described
previously9; 10; 22. Briefly, all protein samples were prepared in 50 mM sodium phosphate, 75
mM NaCl, 2 mM DTT, 0.02% NaN3 (pH 7.2). Unlabeled protein or peptide ligand was added
stepwise to 15N labeled protein and each step was monitored by acquiring a 2D 1H-15N HSQC
spectrum38. The changes in 1H and 15N chemical shifts were quantified using the formula39:
Δδave = {[½[(ΔδH)2 + (0.2ΔδN)2]}1/2. Residues with chemical shift changes above the mean
plus one standard deviation were considered significant. The dissociation constants were
derived from binding curves generated using the Matlab (version 5.3.1, The Mathworks Inc.)
suite of programs by plotting Δδave versus ligand concentration.
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Figure 1. Itk autophosphorylation occurs in cis
(A) Itk deletion fragments used in this study. Y180 in the SH3 domain is the site of
autophosphorylation, K390 is mutated to R to render the kinase domain inactive, Y511 is the
site of trans phosphorylation by Lck. (B) 0.5 μM Itk FL WT was incubated with 0.5 μM kinase
inactive (K390R) versions of the following proteins: Itk ProKD (lane 2), Itk 32KD (lane 3) or
Itk 2KD (lane 4), in a kinase assay buffer. Lane 1 is 1μM Itk FL WT alone. The samples were
boiled, separated by SDS-PAGE and western blotted using an anti-phospho-Y180 or anti-
FLAG antibody. Lanes 5–8: Reversal of the incubation scheme: Itk 32KD WT was incubated
with kinase inactive (K390R) versions of the following proteins: Itk FL (lane 6), Itk ProKD
(lane 7) and Itk 2KD (lane 8). Lane 5 is 1 μM Itk 32KD WT enzyme alone. The Itk 2KD
fragment that lacks the Itk SH3 domain (lanes 4 and 8) is used as a control. (C) Itk FL can
associate with Itk 32KD. Empty FLAG-resin (lanes 1 and 2) or purified FLAG-tagged Itk
32KD immobilized on an anti-FLAG resin (lane 3) was incubated with uninfected Sf9 cell
lysate (lane 1) or untagged Itk FL infected Sf9 cell lysate (lanes 2 and 3) in a pull-down assay.
The samples were rinsed, separated by SDS-PAGE and western blotted using an anti-Itk
antibody. (D) In vivo Itk autophosphorylation occurs in cis. FLAG-tagged Itk 32KD WT, Itk
kinase inactive 32KD (K390R) and Itk FL WT were co-expressed with Lck and
immunoprecipitated from Sf9 cells using an anti-FLAG resin and western blotted as before
with anti-phospho-Y180 or anti-FLAG antibodies. Lane 1: Itk 32KD WT alone, Lane 2: Itk
kinase inactive 32KD (K390R) alone and Lane 3: Itk kinase inactive 32KD (K390R) co-
expressed with Itk FL WT. Arrows on the top panel indicate the positions of Y180
phosphorylated Itk FL and Itk 32KD. Itk 32KD migrates slightly below the immunoglobulin
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heavy chain and a mobility shift associated with the phosphorylated Itk 32KD fragment is
evident in lane 1 (the band is seen both below and slightly above the heavychain). The asterisk
on the top panel indicates the heavy chain that has been displaced by the presence of Itk 32KD.
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Figure 2. Kinetic parameters for Itk Y180F mutant and wild type Itk
(A & B) The in vitro kinase activities of full-length Itk wild-type (WT), Y180F mutant and
Y180F mutant in the presence of 2.5 μM free Itk SH2 domain are compared. Substrate (Peptide
B or ATP) curves of WT full-length Itk (filled triangles), Itk Y180F (open squares), and Y180F
mutant in the presence of free Itk SH2 domain (open circles) were fit to the Michealis-Menten
equation using GraphFit to obtain the kinetic parameters reported in (B). (C) Western blot of
purified Itk enzymes. 250 nM purified Itk WT or Y180F mutant enzymes were separated by
SDS-PAGE, transferred onto PVDF, and probed with either an anti-pY180, anti-pY511 or anti-
FLAG antibody. Y511 phosphorylation levels are comparable for WT and Y180F Itk. (D)
Comparison of the activities of Itk full-length WT enzyme with that of the full-length kinase
inactive (K390R) mutant. One μM enzyme was used for each reaction and Peptide B was used
as substrate. Data shown are the average of at least two independent experiments.
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Figure 3. Mutation of Itk SH3 Y180 to Glu modulates ligand binding by the SH3 domain
300 μM (initial concentration) of either 15N labeled wild type Itk SH3 (A) or 15N labeled SH3
Y180E mutant (B) were titrated with increasing concentration of a proline rich peptide
(GWYSKPPPPIP). In a similar manner, 250 μM (initial concentration) of either 15N labeled
wild type Itk SH3 (C) or 15N labeled SH3 Y180E mutant (D) were titrated with increasing
concentration of unlabeled Itk SH2 domain. 1H-15N HSQC spectra were obtained upon
addition of each aliquot of ligand. Binding curves were generated by plotting the normalized
concentration dependence of amide 1H chemical shifts for resonances corresponding to Y182,
T184, Q188, E189, L192, D202, W208, W209, R210, A221, S223 and S224. (E) Dissociation
constants are derived from the binding curves shown in A–D. Asterisk indicates that the
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dissociation constant for the wild type Itk SH3/SH2 interaction has been reported previously
along with the binding curve shown in (C)22.
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Figure 4. Chemical shift perturbations induced by Itk SH3 Y180E mutation and ligand binding
Purified 15N labeled Itk SH3 WT, or SH3 Y180E mutant were titrated with increasing amounts
of proline rich peptide or Itk SH2 domain. The average chemical shift (Δδave) for each amide
is plotted against the residue number of Itk. The horizontal dashed lines represent the mean
plus one standard deviation for each titration. Residues that exhibit chemical shift changes
above this line are considered significant and are mapped onto the structure of the SH3 domain
in Figure 5. (A) Chemical shift changes upon binding of proline rich peptide to wild type 15N
Itk SH3; (B) Binding of proline rich peptide to Y180E 15N Itk SH3 mutant; (C) Chemical shift
differences between wild type Itk SH3 and the Y180E Itk SH3 mutant. (D) Chemical shift
changes upon binding of Itk SH2 domain to wild type 15N Itk SH3; (E) Binding of Itk SH2
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domain to the Y180E 15N Itk SH3 mutant. Asterisks indicate resonances that broaden beyond
detection upon ligand binding. Such residues are included in the surface maps shown in Figure
5.
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Figure 5. Surface plot of the chemical shift changes upon ligand binding
The color scheme used for all the panels are as follows: The Itk SH3 domain (PDB ID 1AWJ)
is shown in grey and is represented in identical orientations in each panel. Residues
corresponding to resonances that exhibit significant chemical shift changes are shown in red
and the autophosphorylation site Y180 is cyan on each structure. (A) Structure of the Itk SH3
domain (surface rendering) bound to the proline rich (KPLPPTP) ligand (represented as sticks
in green). The conserved binding clefts I and II for the proline peptide on the surface of the
SH3 domain are circled and labeled. (B) Proline rich ligand binding to the wild type Itk SH3
domain. (C) Proline rich ligand binding to the Y180E Itk SH3 mutant. (D) Itk SH2 domain
binding to the wild type Itk SH3 domain. (E) Itk SH2 domain binding to the Y180E Itk SH3
mutant. (F) SH3 residues that exhibit changes in resonance frequencies upon mutation of Y180
to Glu.
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Figure 6. Model of in cis Itk autophosphorylation
(A) The Itk kinase domain (shown in blue, PDB ID 1SNX) was aligned with the structure of
the substrate bound insulin receptor kinase domain (PDB ID 1IR3). The insulin receptor kinase
domain itself is not shown for clarity while the tyrosine containing peptide substrate in that
structure is indicated in orange. Itk Y180 (represented by sticks in red) within the Itk SH3
domain (grey ribbons) was placed into the active site of the kinase domain by superimposing
Y180 (red) with the tyrosine residue of the insulin receptor kinase substrate (orange). To
achieve efficient phosphorylation of Y180 in the SH3 domain, the SH2 domain must dock onto
the Itk kinase domain outside of the active site19. Additionally, the 17-amino acid SH2-kinase
linker contacts the ‘backside’ of the small lobe of the kinase domain (indicated with dashed
line)18. Thus, restraints imposed by the amino and carboxy termini of the SH2 domain and its
neighboring domains (SH3 and kinase) suggest that SH2 docking likely occurs on the small
lobe of the kinase domain (indicated with wide grey arrow). The linear domain structure of the
SH3-SH2-kinase portion of Itk is shown at the bottom of the figure. The enlarged view shown
in (B) more clearly shows the superposition of Y180 with the peptide substrate tyrosine of the
insulin receptor kinase structure. (C) Surface rendering of the Itk kinase domain (blue) and the
Itk SH3 domain (grey). Y180 is red and the ATP binding cleft of the Itk kinase domain is
labeled. Figures 5 and 6 were generated using PyMol40.
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